1996/1997 Publications Page




Leclerc D, Campeau E, Goyette P, Adjalla CE, Christensen B, Ross M, Eydoux P, Rosenblatt DS, Rozen R and Gravel RA: Human methionine synthase: cDNA cloning, chomosomal localization, and identification of mutations in patients of the cblG complementation group of folate/cobalamin disorders. Hum Mol Genet 5:1867-1874, 1996.

Goyette P, Christensen B, Rosenblatt DS and Rozen R: Severe and mild mutations in cis for the methylenetetrahydrofolate reductase (MTHFR) gene, and description of 5 novel mutations in MTHFR. Amer J Hum Genet 59:1268-1275, 1996.

Kassarjian A, Elstein E: ACE genotype distributions differ between sporadic and familial hypertrophic cardiomyopathy. McGill J Med 2(2):73-77, 1996.

Afzal S, Lalani EN, Foulkes WD, Boyce B, Tickle S, Cardillo MR, Baker T, Pignatelli M and Stamp GWH: Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 espression and synthetic matrix metalloproteinase-2 inhibitor binding in ovarian carcinomas and tumour cell lines. Lab Invest 74:406-421, 1996.

Bryan EJ, Watson RH, Davis M, Hitchcock A, Foulkes WD and Campbell IG: Localization of an ovarian cancer tumor suppressor gene to a 0.5cM region between D22S284 and CYP2D, on chromosome 22q. Cancer Res 56:719-721, 1996.

Davis M, Hitchcock A, Foulkes WD and Campbell IG: Refinement of two chromosome 11q regions of heterozygosity in ovarian cancer. Cancer Res 56:741-744, 1996.

Foulkes WD, Bolduc N, Lambert D, Ginsburg O, Yandell DW, Tonin P and Narod SA: Increased incidence of cancer in first degree relatives of women with double primary carcinomas of the breast and colon. J Med Genet 33:534-539, 1996.

Foulkes WD, Brunet J-S, Sieh W, Shenouda G, Black MJ and Narod SA: Familial risks of squamous cell carcinoma of the head and neck. Br Med J 313:716-721, 1996.

Milner BJ, Hosking L, Sun S, Haites NE, Foulkes WD: Polymorphisms in P21CIP1/WAF1 are not correlated with TP53 status in sporadic ovarian tumours. Eur J Cancer 32A:2360-2363, 1996.

Cutler C, Foulkes WD, Brunet J-S, Flanders T, Shibata H and Narod SA: Cutaneous malignant melanoma is uncommonly associated with a family history of melanoma. Melanoma Res 6: 435-440, 1996.

Flanders T and Foulkes WD: Pancreatic adenocarcinoma epidemiology and genetics. J Med Genet 33:889-898, 1996.

Nguyen DM, Gilfix BM, Dennis F, Blank D, Latter DA, Ergina PL, Morin JE, de Varennes B: Impact of transfusion of mediastinal shed blood on serum levels of cardiac enzymes. Ann Thorac Surg 62:109-114, 1996.

Bose S, Komorowski R, Seetharam S, Gilfix B, Rosenblatt DS and Seetharam B: In vitro and in vivo inactivation of TC II receptor by its antiserum. J Biol Chem 271:4195-4200, 1996.

Schuler GD, Boguski MS, Stewart EA, et al. Hudson TJ: A gene map of the human genome. Science 274:540-546, 1996.

Huang S-F, Xiao S, Renshaw AA, Loughlin KR, Hudson TJ and Fletcher JA: Fluorescence in situ hybridization evaluation of chromosome deletion patterns in prostate cancer. Amer J Pathol 149:1565-1573, 1996.

McDermid HE, McTaggart KE, Riazi MA, Hudson TJ, Budarf ML, Emanuel BS and Bell CJ: Long-range mapping and construction of a YAC contig of the cat eye syndrome critical region. Genome Res 6:1149-1159, 1996.

Shearman AM , Hudson TJ, Andresen JM, Wu X, Sohn RL, Haluska F, Housman DE and Weiss JS: The gene for Schnyder's cristalline corneal dystrophy maps to human chromosome 1p36-32. Hum Mol Genet 5:1667-1672, 1996.

Seese N K, Vendetti CP, Chorney KA, Gerhard GS, Ma J, Hudson TJ, Phatak PD and Chorney MJ: Localization of the hemochromatosis disease gene: linkage disequilibrium analysis using an American patient collection. Blood Cells, Molecules, and Diseases 22:36-46, 1996.

Linblad K, Lunkes A, Maciel P, Stevanin G, Zander C, Klockgether T, Ratzlaff T, Brice A, Rouleau GA, Hudson TJ, Auburger G and Schalling M: Mutation detection in Machado-Joseph disease using repeat expansion detection. Molecular Medicine 2:77-85, 1996.

Treacy E, Arbour L, Chessex P, Graham G, Kasprzak L, Casey L, Bell L, Mamer O and Scriver CR: Glutathione deficiency as a complication of methylmalonic acidemia: Response to high doses of ascorbate. J Pediatr 129:445-448, 1996.

Fujiwara TM, Morgan K, Bichet DG: Invited commentary: Molecular analysis of X-linked nephrogenic diabetes insipidus. Eur J Endocr 134:675-677, 1996.

Naumova AK, Plenge RM, Bird LM, Leppert M, Morgan K. Willard HF, and Sapienza C: Heritability of X chromosome-inactivation phenotype in a large family. Amer J Hum Genet 58:1111-1119, 1996.

Pardo-Manuel de Villena F, Slamka C, Fonseca M, Naumova AK, Paquette J, Pannunzio P, Smith M, Verner A, Morgan K, and Sapienza C: Transmission-ratio distortion through F1 females at chromosome 11 loci linked to Om in the mouse DDK syndrome. Genet 142:1299-1304, 1996.

Phelan CM, Larsson C, Baird S, Futreal PA, Ruttledge MH, Morgan K, Tonin P, Hung H, Korneluk RG, Pollak MN , and Narod SA: The human mammary-derived growth inhibitor (MDGI) gene: genomic structure and mutation analysis in human breast tumours. Genomics 34:63-68, 1996; Erratum Genomics 36:377, 1996.

Richter A, Poirier J, Mercier J, Julien D, Morgan K, Roy M, Gosselin F, Bouchard J-P, and Melanon SB: Friedreich ataxia in Acadian families from Eastern Canada: clinical diversity with conserved haplotypes. Amer J Med Genet 64:594-601, 1996.

Turecki G, Rouleau GA, Joober J, Mari J, and Morgan K: Schizophrenia and chromosome 6p. Amer J Med Genet 67, 1996.

Turecki G, Rouleau GA, Mari JJ, and Morgan K: A systematic evaluation of linkage studies in bipolar disorder. Acta Psychiatrica Scan 93:317-326, 1996.

Weiler T, Greenberg CR, Nylen E, Halliday W, Morgan K, Eggertson D, and Wrogemann W: Limb-girdle muscular dystrophy and Miyoshi myopathy in an aboriginal Canadian kindred map to LGMD2B and segregate with the same haplotype. Amer J Hum Genet 59:872-878, 1996.

Drennan CL, Matthews RG, Rosenblatt DS, Ledley FD, Fenton WA and Ludwig ML: Molecular basis for dysfunction of some mutant forms of methylmalonyl-CoA mutase: deductions from the structure of methionine synthase. Proc Nat Acad Sci (USA) 93:5550-5555, 1996.

Watanabe F, Saido H, Yamaji R, Kazutaka M, Isegawa Y, Ito A, Yubisui T, Rosenblatt DS and NakanoY: Biochemical and molecular roles of nutrients. Mitochondrial NADH- or NADPH-linked aquacobalamin reductase activity is low in human skin fibroblasts with defects in synthesis of cobalamin coenzymes. J Nutr 126:2947-2951, 1996.

Lopes-Cendes I, Silveira I, Maciel P, Gaspar C, Radvany J, Chitayat D, Babul R, Stewart J, Dolliver M, Robitalle Y, Rouleau GA, and Sequeiros J: Limits of clinical assessment in the accurate diagnosis of Machado-Joseph disease. Archives Neurology 53:1168-1174, 1996.

Cavazzoni P, Alda M, Turecki G, Rouleau GA, Grof E, Martin R, Duffy A, Grof P: Lithium-responsive affective disorders: no association with the tyrosine hydroxylase gene. Psychiatry Res 64:91-96, 1996.

Lafreniere R, Rochefort D, Kibar Z, Fon E, Han F.-Y, Cochius J, Kang X, Baird S, Korneluk R, Andermann E, Rommens J, and Rouleau GA: Isolation and characterization of GT335, a novel human gene conserved in Escherichia coli and mapping to 21q22.3. Genomics 38:264-272, 1996.

Lafreniere R, Rochefort D, Chretien N, Neville C, Korneluk R, Zuo L, Wei Y, Lichter J and Rouleau GA: Isolation and genomic structure of a human homolog of the yeast periodic tryptophan protein 2 (PWP2) gene mapping to 21q22.3. Genome Res 6:1216-1226, 1996.

Turecki G, Rouleau GA, Mari JJ and Morgan K: A systematic evaluation of linkage studies in bipolar disorder. Acta Psychiatrica Scand 93:317-326, 1996.

Gaspar C, Lopes-Cendes I, DeStefano AL, Maciel P, Silveira I, Coutinho P, MacLeod P, Sequeiros J, Farrer LA and Rouleau GA: Linkage disequilebrium analysis in Machado-Joseph disease patients of different ethnic origins. Hum Genet 98:620-624, 1996.

Turecki G, Alda M, Grof P, Grof E, Martin R, Cavazzoni P, Duffy A, Maciel P and Rouleau GA: No association between chromosome 18 markers and lithium responsive affective disorders. Psychiatry Res 63:17-23, 1996.

Turecki G, Grand’Maison F, Lemieux B and Rouleau GA. Hyperekplexia and the alpha subunit glycine receptor gene (GLRA1). Archives Neur 53:836-837, 1996.

Pulst S, Nechiporuk A, Neciporuk T, Gispert S, Chen X, lopes-Cendes I, Pearlman S, Starkman S, Orozco-Diaz G, Lunkes A, DeJong P, Rouleau GA, Auburger G, Korenberg J, Figueroa C and Sahba S: Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nat Genet 14:269-276, 1996.

Dubé, M.P., Mlodzienski M, Kibar Z, Farlow M, Eber G, Harper P, Kolodny E, Rouleau GA and Figlewicz D: Hereditary spastic paraplegia: LOD-score consideration for confirmation of linkage in a heterogeneous trait. Amer J Hum Genet 60:625-629, 1996.

Lafreniere R, Rochefort D, Chretien N, Rommens J, Cochius J, Kaliainen R, Nousiainen U, Patry G, Farrell K, Soderfeld B, Federico A, Hale B, Hernandez-Cossio O, Sorensen T, Pouliot M, Kmiec T, Uldall P, Halasz P, Pranzatelli M, Andermann F, Andermann E and Rouleau GA: Unstable insertion in the 5' flanking region of the cystatin B gene is the most common mutation in progressive myoclonus epilepsy type 1 (EPM1). Nat Genet 15:298-302, 1996.

Marcus JN, Watson P, Page DL, Narod SA, Tonin P, Linder-Stephenson L, Salerno G, Conway TA and Lynch HT: Hereditary breast cancer: pathobiology, prognosis and BRCA1 and BRCA2 gene linkage. Cancer 77:697-709, 1996.

Serova O, Montana M, Torchard D, Narod SA, Tonin P, Sylla B, Lynch HT, Feunteun J, and Lenoir GM: BRCA1 mutations in 20 breast-ovarian cancer families. Am J Hum Genet 58:42-51, 1996.

Neuhausen SL, Mazoyer S, Friedman L, Stratton M, Offit K, Caligo A, Tomlinson G, Cannon-Albright L, Bishop T, Kelsell D, Sollomon E, Weber B, Couch F, Struewing J, Tonin P, Durocher F, Narod SA, Skolnick MH, Lenoir GM, Serova O, Ponder B, Stoppa-Lyonnet D, Easton D, King M-C, and Goldgar DE: Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: Results of an international study. Am J Hum Genet 58:271-280, 1996.

Phelan CM, Lancaster JM, Tonin P, Gumbs C, Carter R, Ghadirian P, Perret C, Moslehi R, Dion F, Faucher M-C, Dole K, Karimi S, Foulkes W, Lounis H, Warner E, Goss P, Anderson D, Larsson C, Narod SA and Futreal PA: Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families. Nat Genet 13:121-123, 1996.

Rahman N, Arbour L, Tonin P, Renshaw J, Pelletier J, Baruchel S, Pritchard-Jones K, Stratton MR, and Narod SA: Evidence for familial Wilms' tumour gene (FWT1) on chromosome 17q12-21. Nat Genet 13:461-463, 1996.

Lerman C, Narod SA, Schulman K, Hughes C, Gomez-Caminero A, Bonney G, Gold K, Tock B, Main D, Lynch J, Fulmore C, Synder C, Lemon SJ, Conway T, Tonin P, Lenoir GM, Lynch H: BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. J Am Med Assoc 275:1885-1892, 1996.

Durocher F, Tonin P, Shattuck-Eidens D, Skolnick M, Narod SA, and Simard J: Mutation analysis of the BRCA1 gene in 24 families with cases of cancer in the breast, ovary and multiple other sies. J Med Genet 33:814-819, 1996.

Tonin P, Weber B, Offit K, Couch F, Rebbeck TR, Neuhausen S, Godwin AK, Daly M, Wagner-Costalos J, Berman D, Grana G, Fox E, Kane MF, Kolodner RD, Krainer M, Haber DA, Struewing JP, Warner E, Rosen B, Lerman C, Peshkin B, Norton L, Serova O, Foulkes WD, Lynch HT, Lenoir GM, Narod SA and Garber JE: Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families. Nat Med 2:1179 -1183, 1996.

Watkins D, Ruttledge M, Sarrazin J, Rangaratnam S, Poisson M, Delattre J-Y and Rouleau GA: Loss of heterozygosity on chromosome 22 in human gliomas does not inactivate the neurofibromatosis type 2 gene. Can Genet Cytogenet 92:73-78, 1996.



Foulkes WD and Narod SA: Screening for cancer In high risk populations, in Cancer Screening. Miller, A.B., ed., Kluwer Academic, Boston, MA, pp. 165-182, 1996.



Adjalla CE, Hosack AR and Rosenblatt DS: A common mutation in mut- methylmalonic aciduria. Clin Invest Med 19:S54, 1996.

Christensen B, Goyette P, Al-Hendy A, Rosenblatt DS and Rozen R: New mutation identified in four unrelated patients with methylenetetrahydrofolate reductase deficiency. Pediatr Res 39:143A, 1996.

Elstein E, Huan C: Polymorphisms in genes of ACE, angiotensinogen, nitric oxide synthase and endothelin are not associated with cardiac allograft vasculopathy. Sixth International Alexis Carrel Conference on Graft Atherosclerosis and Chronic Rejection. December 4-7, 1996.

Elstein E and Huan C: The D allele of the ACE gene in cardiac allografts may be associated with rejection. Sixth International Alexis Carrel Conference on Graft Atherosclerosis and Chronic Rejection. December 4-7, 1996.

Briones L, Silver B, Gilfix BM: The use of two laboratory tests in the diagnosis of dementia: apolipoprotein E genotyping and the pupil dilation response. Génétique Humaine Au Québec: "Qui Fait Quoi ?" Les Journés de Génétique Humaine RMGA-FRSQ 1996.

Gilfix BM, Briones L: The use of polymorphisms of apolipoprotein E and angiotensin -converting enzymes as markers for dementia in a clinical setting. Clin Invest Med 19(4): S50, 1996.

O'Neil WM, Gilfix BM, DiGirolamo A, Tsoukas CM, Wainer IW: The effect of HIV-related disease progression on N-acetyltransfersae 2 activity. International AIDS 1996.

Arthus M-F, Lonergan M, Platzer M, Rosenthal A, Robertson G, Fujiwara M, Morgan K, Bichet DG: Large deletions/rearrangements of the AVPR2 gene causing X-linked nephrogenic diabetes insipidus. J Amer Soc Nephrol 7:1610, 1996.

Byck S, Morgan K, Blanc L, and Scriver CR: The PAH locus and population genetic variation: The Quebec example. (platform presentation) Amer J Hum Genet 59:A30, 1996.

Hupé P, Lonergan M, Arthus M-F, Daoust M, Fujiwara M, Morgan K, and Bichet DG: Haplotype heterogeneity in the French-Canadian polycystic kidney disease I families. J Amer Soc Nephrol 7:1614, 1996.

Melançon SB, Morgan K, Julien D, Mercier J, Poirier J, Pandolfo M, and Richter A: Classical Friedreich's ataxia (FRDA), Acadian FRDA and Acadian spastic ataxia: Different clinical manifestations of the (GAA) expansion in the Frataxin gene. Amer J Hum Genet 59:A271, 1996.

Olien K, Naumova A, Sapienza C, and Morgan K: Heritability of X-chromosome inactivation skewing. Génétique humaine au Québec: "Qui fait quoi?" Le Réseau FRSQ de médecine génétique appliquée, 18-19 June 1996, Montreal, p. 30.

Pardo-Manuel de Villena, F, Morgan K, and C. Sapienza: A distorter locus acting through F1 females in the Om region in the DDK syndrome. Institut Pasteur, Paris, p. 116.

RichterA, Morgan K, Bouchard J-P, Mathieu J, Potier M, Vanier M, Lamarche J, Michaud J, and Melançon SB: ARSACS: possible indication of lysosomal enzyme defects and the Généthon mapping approach. Génétique humaine au Québec: "Qui fait quoi?" Le Réseau FRSQ de médecine génétique appliquée, 18-19 June 1996, Montreal, p. 59.

Richter A, Morgan K, Bouchard JP, Mathieu J, Lamarche J, Rioux J, Hudson T, and Melançon SB: ARSACS: Possibly a lysosomal storage disease? Amer J Hum Genet 59:A379, 1996.

Rousseau F, Morel ML, Rouillard P, Khandjian EW, and Morgan K: Prévalence étonnamment faible d'hommes porteurs de prémutations X-fragile dans la population generale. Génétique humaine au Québec: "Qui fait quoi?" Le Réseau FRSQ de médecine génétique appliquée, 18-19 June 1996, Montreal, p. 31.

Rousseau F, Morel ML, Rouillard P, Khandjian EW, and Morgan K: Surprisingly low prevalence of FMR1 premutations among males from the general population. Amer J Hum Genet 59:A188, 1996.

Scriver, CR, and Morgan K: Disease-producing alleles as migration traces. 64e Congrès de L'ACFAS, Colloque 516: Les gènes constituent une mémoire biologique, Mogramme General, p. 169, 1996.

Turecki G, Rouleau G, and Morgan K: Exploring different phenotypic models in parametric linkage analysis of bipolar disorder and chromosome 18 genetic markers. Genetic Analysis Workshop 10, 27-29 October 1996, Pajaro Dunes Conference Center, Watsonville, CA, Vol. 1, pp. 108-112, 1996.

Weiler T, Greenberg CR, Nylen E, Halliday W, Morgan K, and Wrogemann K: Limb girdle muscular dystrophy and Miyoshi myopathy map to LGMD2B and segregate with the same haplotype. Canada Bulletin 27(2):40, 1996.

Weiler T, Greenberg CR, Zelinski T, Morgan K, Nylen E, Nickel B, and Wrogemann K: A limb girdle muscular dystrophy locus in Manitoba Hutterites does not map to the known LGMD loci. Amer J Hum Genet 59:A390, 1996.

River Y, Lossos A, Gutman A, Abrumsky O, and Rosenblatt DS: Neurobehavioral impairment in siblings with adult-onset methylenetetrahydrofolate reductase deficiency. Neurology 46:A365, 1996.

Steen C, Rosenblatt DS, Schenying H, Breauer HC, Kohlschütter A: Cobalamin E (cblE) disease: a severe neurological disorder with megaloblastic anemia, homocystinuria and low serum methionine. J Inher Metab Dis 19:41(P82), 1996.

Augoustides-Savvopooulou P, Gompakis N, Rosenblatt DS, Seetharam B, Sewell A, Zafiriu D, Tsantali C, Tsaousi C, Tsangaroupoulou C and Kanakoudi F: Transcobalamin II (TCII) deficiency in a Greek infant. J Inher Metab Dis 19:40, 1996.

Arn PH, Williams CA, Zori RT, Driscoll DJ and Rosenblatt DS: Methylenetetrahydrofolate reductase (MTHFR) deficiency in a patient with phenotypic features of Angelman syndrome (AS). Amer J Hum Genet 59:A86, 1996.

Leclerc D, Goyette P, Campeau E, Christensen B, Adjalla CE, Rosenblatt DS, Rozen R and Gravel RA: Cloning human methionine synthase and identification of mutations in patients of the cblG complementation group. Amer J Hum Genet 59:A42, 1996.

Rosenblatt DS, Sun S, Chan A, Evans S, Adjalla CE and Hosack AR: Six novel mutations in mut methylmalonic aciduria. Amer J Hum Genet 59:A206, 1996.

Tonin P, Ghadirian P, Lynch H, Lenoir G and Narod SA: Linkage analysis of the BRCA2 locus at chromosome 13q12-13 in hereditary breast cancer families. Amer J Hum Genet 57:A37, 1996.

Tonin, P, Provencher D, Narod SA, Gauthier J, Drouin P and Mes-Masson A-M: Low frequency of LOH at the BRCA1 locus in unselected epithelial ovarian cancers. Gynecol Oncol J 60:151, 1996.

Lounis H, Tonin P, Eydoux P, Provencher D, Drouin P, Duduc-Lissoir J and Mes-Masson A-M: Mapping chromosomes 3p deletions in epithelial ovarian cancer (EOC). Gynecol Oncol J 60:150, 1996.

Tonin P, Mes-Masson A-M, Mahon M, Goddard B, Narod SA and Provencher D: Use of tumour material to improve risk assessment of BRCA1 carriers. Gynecol Oncol J 60:150, 1996.

Tonin P, Durocher F, Simard J, Latreille J, Mes-Masson A-M, Provencher D, Narod SA and Ghadirian P: Genetic epidemiology of breast and ovarian cancer in French-Canadians: Common BRCA1 and BRCA2 mutations. Les Journes de Genetique Humaine au Quebec "Qui fait quoi?, Réseau de médicine génétique appliquée - FRSQ, Montreal, 1996.

Provencher D, Mes-Masson A-M, Mahon M, Goddard B, Narod SA and Tonin P: Use of ovarian tumour material to improve risk assessment of BRCA1 carriers. Annual Meeting of the Gynecologists and Obstetricians of Canada, Quebec, Quebec, 1996.

Lounis H, Tonin P, Eydoux P, Provencher D, Drouin P, Dubuc-Lissoir J and Mes-Masson A-M: Mapping chromosome 3p alterations in epithelial ovarian cancer. Annual Meeting of the Gynecologists and Obstetricians of Canada, Quebec, 1996.

Tonin, P, Lounis H, Dion F, Provencher D and Mes-Masson A-M: Evaluation of the chromosome 3p gene, FHIT, in unselected human epithelial ovarian tumours. Annual Meeting of the Gynecologists and Obstetricians of Canada, Quebec, 1996.

Provencher DM, Lounis H, Champoux L, Eydoux P, Tonin PN and Mes-Masson A-M: Characterization of five new human ovarian cell lines, including one cell line derived from normal ovarian epithelium. Annual Meeting of the Gynecologists and Obstetricians of Canada, Quebec, 1996.

Marcus JN, Watson P, Page DL, Narod SA, Tonin P, Serova O, Lenoir GM and Lynch HT: BRCA2 and BRCA1 breast cancer phenotypes. United States and Canadian Academy of Pathology, 1996.

Lounis H, Mes-Masson A-M, Dion F, Champoux L, Provencher D and Tonin P: Mapping chromosome 3p alterations in tumour biopsies and in primary cultures of ovarian epithelial tumours. Cancer Genetics & Tumour Suppressor Genes, Cold Spring Harbour Laboratory August 14-18, 1996.

Watkins D: Complementation analysis of abnormal cobalamin metabolism in methionine dependent melanoma cell line MeWoLC1. Clin Invest Med 19:S54, 1996.



Rosenblatt DS: Nurturing the clinical investigator: the task continues! Clin Invest Med 19:55-58, 1996. (Presidential Address).

Rosenblatt DS and Narod SA: Genetic screening for breast cancer. New Engl J Med 334:1200-1201, 1996. (Letter).

Rosenblatt DS, Fraser FC, Roy DJ: Folic acid to prevent neural tube defects: time for food fortification. Clin Invest Med 19:202-203, 1996. (Editorial).

Bapat B, Xia L, Madlensky L, Mitri A, Tonin P, Narod SA, Gallinger S: The genetic basis of Muir-Torre syndrome includes the hMLH1 locus. Am J Hum Genet 59:736-739, 1996. (Letter)

| Top | Home | McGill |

©1997 PMNowacki Ent®
for Finestone Laboratory